[go: up one dir, main page]

GB1403732A - Tetrahydropyrimidines imidazolines and tetrahydro-1,3- diazepines - Google Patents

Tetrahydropyrimidines imidazolines and tetrahydro-1,3- diazepines

Info

Publication number
GB1403732A
GB1403732A GB1119972A GB1119972A GB1403732A GB 1403732 A GB1403732 A GB 1403732A GB 1119972 A GB1119972 A GB 1119972A GB 1119972 A GB1119972 A GB 1119972A GB 1403732 A GB1403732 A GB 1403732A
Authority
GB
United Kingdom
Prior art keywords
tetrahydropyrimidines
diazepines
imidazolines
tetrahydro
tetrahydropyrimidines imidazolines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1119972A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Priority to GB1119972A priority Critical patent/GB1403732A/en
Priority to US472759A priority patent/US3926994A/en
Priority to US05/582,038 priority patent/US3996207A/en
Priority to US05/582,043 priority patent/US3965112A/en
Publication of GB1403732A publication Critical patent/GB1403732A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
GB1119972A 1971-01-11 1972-11-30 Tetrahydropyrimidines imidazolines and tetrahydro-1,3- diazepines Expired GB1403732A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB1119972A GB1403732A (en) 1971-12-14 1972-11-30 Tetrahydropyrimidines imidazolines and tetrahydro-1,3- diazepines
US472759A US3926994A (en) 1971-01-11 1974-05-23 Heterocyclic compounds
US05/582,038 US3996207A (en) 1971-01-11 1975-05-29 Derivatives of tetrahydro-1H-1,3-diazepine and hexahydro-1,3-diazocine
US05/582,043 US3965112A (en) 1971-01-11 1975-05-29 Imidazoline derivatives

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1120072 1971-12-14
GB1206972 1972-03-15
GB1119972A GB1403732A (en) 1971-12-14 1972-11-30 Tetrahydropyrimidines imidazolines and tetrahydro-1,3- diazepines

Publications (1)

Publication Number Publication Date
GB1403732A true GB1403732A (en) 1975-08-28

Family

ID=27256659

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1119972A Expired GB1403732A (en) 1971-01-11 1972-11-30 Tetrahydropyrimidines imidazolines and tetrahydro-1,3- diazepines

Country Status (1)

Country Link
GB (1) GB1403732A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0478994A1 (en) * 1990-09-22 1992-04-08 Bayer Ag Process for the preparation of 5-hydroxy-3,4,5,6,-tetra hydro-pyrimidine derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0478994A1 (en) * 1990-09-22 1992-04-08 Bayer Ag Process for the preparation of 5-hydroxy-3,4,5,6,-tetra hydro-pyrimidine derivatives
US5162529A (en) * 1990-09-22 1992-11-10 Bayer Aktiengesellschaft Process for the preparation of 5-hydroxy-3,4,5,6-tetrahydro-pyrimidine derivatives

Similar Documents

Publication Publication Date Title
IE39301B1 (en) 3-alkyl-4-oxo imidazolidines and their 1-oxyls
ZA723502B (en) Azole derivatives
GB1403866A (en) Derivatives of 3-amino-1,2,4-triazoles
AU469978B2 (en) Imidazolidines
AU467499B2 (en) Imidazo-diazepines, pyrimidines and imidazoles
GB1400425A (en) Substituted 3-hydroxymethyl-isoquinolines and derivatives
ZA73620B (en) Nitrogen-containing compounds and use thereof
IL40271A0 (en) Pyrimidine derivatives and fungicidal compositions containing them
IL40123A0 (en) Imidazolines and their preparation
GB1403732A (en) Tetrahydropyrimidines imidazolines and tetrahydro-1,3- diazepines
PH9906A (en) Tetrahydropyrimidines,imidazolines and tetrahydro-1,3-diazepines
AU475629B2 (en) Tetrahydo-pyrimidines, imidazolines and tetrahydro-1, 3-diazepines
ZA726310B (en) New nitrofuran derivatives and the preparation thereof
IL39985A0 (en) 2-(3,4-dichloroanilino)quinolizinium bromide and its manufacture
AU4190272A (en) 2,5-bis-substituted pyrimidines
ZA727504B (en) Nitrofuran derivatives and the preparation thereof
ZA724878B (en) Imidazolines
ZA727999B (en) Derivatives of tetrahydropyrimidine,imidazoline and tetrahydro-1,3-diazepine
AU4455572A (en) Quinazolinone derivatives
PH11341A (en) Phenylouralkylamines and derivatives thereof
CA887098A (en) 1-(4-oxopent-1-enyl)-1,3-dimethyl-cyclohex-2-ene, 1-(4-oxopent-1-enyl)-1,3-dimethylcyclohex-3-ene and their methyl homologs
ZA724968B (en) New heterocycles
ZA713932B (en) New nitrofuran derivatives and the preparation thereof
IL38791A0 (en) 2,3-benzoxazepine derivatives
CA33846S (en) Pocket tool

Legal Events

Date Code Title Description
PS Patent sealed
746 Register noted 'licences of right' (sect. 46/1977)
PCNP Patent ceased through non-payment of renewal fee